PharmaShots | Incisive News in 3 Shots

Subscribe Now

Secura Bio

Secura Bio Reports Completion of Enrollment in P-II (PRIMO) Study of Copiktra (duvelisib) for the Treatment of Peripheral T-cell Lymphoma

Secura Bio Reports Completion of Enrollment in P-II (PRIMO) Study of Copiktra (duvelisib) for the Treatment of Peripheral T-cell L...

February 9, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us